The U.S. Food and Drug Administration (FDA) authorized the use of the Lucira™ COVID-19 All-In-One Test Kit under an Emergency Use Authorization (EUA) on November 17, 2020.  This is the first at-home nasal swab test kit to detect SARS-CoV-2  the virus that causes the coronavirus disease 2019 (COVID-19). Read more...

Listed below are brief updates on several recent policy developments across the country. Read more...

The New York Workers’ Compensation Board (WCB) has temporarily suspended application of drug formulary refill/renewal requirements, moving them from January 1, 2021, to an undetermined date at this time. Read more...

During the recent National Alliance of Medicare Set-Aside Professionals (NAMSAP), now known as the National Medicare Secondary Payer Network, annual conference, John Jenkins, Health Insurance Specialist, Division of Medicare Secondary Payer Program Operations, Office of Financial Management for the Centers for Medicare and Medicaid Services (CMS) provided information on the appropriate method for calculating seed money for annuities involving a Workers’ Compensation Medicare Set-Aside (WCMSA) within the total settlement amount. Read more...

Listed below are brief updates on several recent policy developments across the country. Read more...

Evzio auto-injector and naloxone auto-injector have been discontinued and will no longer be available, according to kaléo Inc. (kaléo). According to information Optum has obtained from kaléo, previously dispensed Evzio and its authorized generic are still safe to use until their expiration dates. In addition, pharmacies may dispense current stock, but future refills will not likely be available. Read more...